Zydus receives final approval from USFDA for esomeprazole magnesium
Esomeprazole magnesium for delayed-release oral suspension, 20 mg and 40 mg had annual sales of $42 mn in the United States08-06-2023
08-06-2023
ZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Disclosure under Insider Trading Regulations07-06-2023
ZYDUS WELLNESS LTD.-$ - 531335 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of share certificate / issue of duplicate share certificate under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations)30-05-2023
ZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Analyst / Institutional Investors' Meet29-05-2023
ZYDUS WELLNESS LTD.-$ - 531335 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of share certificate / issue of duplicate share certificate under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations)26-05-2023
ZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Analyst / Institutional Investors' Conference25-05-2023
Neutral Zydus LifeSciences; target of Rs 550: Motilal Oswal
Motilal Oswal recommended Neutral rating on Zydus LifeSciences with a target price of Rs 550 in its research report dated May 18, 2023.23-05-2023
SC seeks response of firm Delhi marketing on plea by Zydus against HC order
The Supreme Court on Monday sought the response of a firm to a plea filed by consumer goods company Zydus Wellness challenging an order of the Delhi high court which held that it cannot use the brand name "SugarLite" for its products. A vacation bench of Justices J K Maheshwari and P S Narasimha issued notice to the firm named Delhi Marketing and sought its reply within three weeks. The top court was hearing an appeal filed by Zydus Wellness against the May 12 order of the high court which restrained it from using the brand name "SugarLite" as Delhi Marketing held the rights to use the brand name "SUGARLITE". The firm alleged that Zydus was using a deceptively similar trademark to confuse the customers and sought directions to restrain the company that manufactures nutrition and skin care products from using the SugarLite' brand name. Initially, Delhi Marketing had moved trial court in 2020 seeking permanent injunction for using the trademark SugarLite or any other identical or...22-05-2023
ZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Transcript of the Earnings Conference call held on May 17, 202322-05-2023
Accumulate Zydus Lifesciences; target of Rs 520: Prabhudas Lilladher
Prabhudas Lilladher recommended accumulate rating on Zydus Lifesciences with a target price of Rs 520 in its research report dated May 18, 2023.20-05-2023